Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin adjustment after betamethasone in insulin-treated pregnant patients with preterm labor
IRCT20220215054031N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin and betamethasone in gestational diabetes mellitus (GDM), diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM) and 1 more (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Average blood sugar after betamethasone treatment, Increase in insulin dosage and 3 more. Started Apr 2022; status: completed.
02
Drugs
human insulinbetamethasone
03
Conditions
gestational diabetes mellitus (GDM)diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)Preterm labor (PTL)
Beyond the preview
Go deeper on IRCT20220215054031N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220215054031N1.